Cell Reprogramming in Tumorigenesis and Its Therapeutic Implications for Breast Cancer
Open Access
- 12 April 2019
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 20 (8) , 1827
Abstract
Breast cancer is the most common malignancy in women worldwide and can be categorized into several subtypes according to histopathological parameters or genomic signatures. Such heterogeneity of breast cancer can arise from the reactivation of mammary stem cells in situ during tumorigenesis. Moreover, different breast cancer subtypes exhibit varieties of cancer incidence, therapeutic response, and patient prognosis, suggesting that a specific therapeutic protocol is required for each breast cancer subtype. Recent studies using molecular and cellular assays identified a link between specific genetic/epigenetic alterations and distinct cells of origin of breast cancer subtypes. These alterations include oncogenes, tumor suppressor genes, and cell-lineage determinants, which can induce cell reprogramming (dedifferentiation and transdifferentiation) among two lineage-committed mammary epithelial cells, namely basal and luminal cells. The interconversion of cell states through cell reprogramming into the intermediates of mammary stem cells can give rise to heterogeneous breast cancers that complicate effective therapies of breast cancer. A better understanding of mechanisms underlying cell reprogramming in breast cancer can help in not only elucidating tumorigenesis but also developing therapeutics for breast cancer. This review introduces recent findings on cancer gene-mediated cell reprogramming in breast cancer and discusses the therapeutic potential of targeting cell reprogramming.Keywords
Funding Information
- Ministry of Science and Technology, Taiwan (MOST106-2314-B-442-001-MY3; MOST106-2320-B-037-001-MY3)
This publication has 81 references indexed in Scilit:
- Potential application of cell reprogramming techniques for cancer researchCellular and Molecular Life Sciences, 2018
- Direct Cardiac Reprogramming: A Novel Approach for Heart RegenerationInternational Journal of Molecular Sciences, 2018
- Clonal analysis of Notch1-expressing cells reveals the existence of unipotent stem cells that retain long-term plasticity in the embryonic mammary glandNature Cell Biology, 2018
- Early lineage segregation of multipotent embryonic mammary gland progenitorsNature Cell Biology, 2018
- Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathwayCell Cycle, 2013
- Induction of cells with cancer stem cell properties from nontumorigenic human mammary epithelial cells by defined reprogramming factorsOncogene, 2013
- A Mammary Stem Cell Population Identified and Characterized in Late Embryogenesis Reveals Similarities to Human Breast CancerCell Stem Cell, 2012
- Antagonistic roles of Notch and p63 in controlling mammary epithelial cell fatesCell Death & Differentiation, 2010
- GATA-3 Maintains the Differentiation of the Luminal Cell Fate in the Mammary GlandCell, 2006
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006